List all clinical trials by discovery date. Accepts regular expressions in search.

GET /trials/?page=73
HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept

{
    "count": 768,
    "next": "http://api.gregory-ms.com/trials/?page=74",
    "previous": "http://api.gregory-ms.com/trials/?page=72",
    "results": [
        {
            "trial_id": 48,
            "title": "A Multicenter Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab",
            "summary": "<b>Condition</b>:    Relapsing Multiple Sclerosis<br/><b>Interventions</b>:    Other: Ofatumumab;   Other: Covid-19 vaccine<br/><b>Sponsor</b>:    Novartis Pharmaceuticals<br/><b>Not yet recruiting</b>",
            "published_date": "2021-04-19T16:00:00Z",
            "discovery_date": "2021-04-19T11:50:37Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04847596?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 46,
            "title": "Effects of Lutein Supplementation on Cognition and MPOD in Multiple Sclerosis Patients-",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br/><b>Interventions</b>:    Dietary Supplement: Lutein;   Dietary Supplement: Placebo<br/><b>Sponsors</b>:    University of Illinois at Urbana-Champaign;   Division of Nutritional Sciences, University of Illinois at Urbana-Champaign<br/><b>Recruiting</b>",
            "published_date": "2021-04-14T16:00:00Z",
            "discovery_date": "2021-04-14T10:53:38Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04843813?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 47,
            "title": "Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised People",
            "summary": "<b>Conditions</b>:    Autoimmune or Autoinflammatory Diseases;   HIV;   Multiple Sclerosis;   Solid Tumors or Cancers;   Solid Organ Transplant<br/><b>Intervention</b>:    Other: Blood samples for the study of the humoral response to SARS-CoV-2 variants and of the cellular response after vaccination against COVID-19<br/><b>Sponsor</b>:    Assistance Publique - Hôpitaux de Paris<br/><b>Not yet recruiting</b>",
            "published_date": "2021-04-14T16:00:00Z",
            "discovery_date": "2021-04-14T10:53:38Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04844489?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 45,
            "title": "Vaccine-generated Immunity in Ocrelizumab-treated Patients: Longitudinal Assessments (VIOLA)",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br/><b>Intervention</b>:    Drug: SARS-COV-2 mRNA Vaccine<br/><b>Sponsor</b>:    NYU Langone Health<br/><b>Not yet recruiting</b>",
            "published_date": "2021-04-14T16:00:00Z",
            "discovery_date": "2021-04-14T10:53:38Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04843774?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 44,
            "title": "The Effect of Telerehabilitation Based Pilates Training in Multiple Sclerosis Patients",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br/><b>Intervention</b>:    Other: Telerehabilitation-based Pilates Exercise<br/><b>Sponsor</b>:    Gazi University<br/><b>Recruiting</b>",
            "published_date": "2021-04-09T16:00:00Z",
            "discovery_date": "2021-04-09T13:11:11Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04838886?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 43,
            "title": "TELEMS: Feasibility of Remote Patient Visits in MS",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br/><b>Interventions</b>:    Other: EDSS;   Other: Discussion of symptoms<br/><b>Sponsor</b>:    Medical University of Vienna<br/><b>Recruiting</b>",
            "published_date": "2021-04-09T16:00:00Z",
            "discovery_date": "2021-04-09T13:11:11Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04838990?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 40,
            "title": "Effect of Disease Modifying Therapy on Antibody Response to COVID19 Vaccination in Multiple Sclerosis",
            "summary": "<b>Conditions</b>:    Multiple Sclerosis;   Covid19<br/><b>Intervention</b>:    <br/><b>Sponsor</b>:    St. Barnabas Medical Center<br/><b>Recruiting</b>",
            "published_date": "2021-04-07T16:00:00Z",
            "discovery_date": "2021-04-08T11:57:29Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04834401?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 38,
            "title": "Therapeutic Adherence of Multiple Sclerosis Patients",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br/><b>Intervention</b>:    Other: Study of the role of sociocognitive factors<br/><b>Sponsor</b>:    Lille Catholic University<br/><b>Not yet recruiting</b>",
            "published_date": "2021-04-08T16:00:00Z",
            "discovery_date": "2021-04-08T11:57:29Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04837352?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 39,
            "title": "Impact of Neuropsychological Disorders in Multiple Sclerosis",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br/><b>Intervention</b>:    Other: Three dimensional gait analysis with eyetracking<br/><b>Sponsor</b>:    Lille Catholic University<br/><b>Not yet recruiting</b>",
            "published_date": "2021-04-08T16:00:00Z",
            "discovery_date": "2021-04-08T11:57:29Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04837365?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 41,
            "title": "Retrospective Study on Registry Data to Evaluate the Impact of Ocrelizumab Used in Routine Care in Patients With RRMS",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br/><b>Intervention</b>:    <br/><b>Sponsor</b>:    University Hospital, Strasbourg, France<br/><b>Recruiting</b>",
            "published_date": "2021-04-08T16:00:00Z",
            "discovery_date": "2021-04-08T11:57:29Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04838015?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        }
    ]
}